Toward HLA epitope matching in clinical transplantation

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3059-3060

  Tambur, A R ^a   Claas, F H J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN;

EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOGENICITY; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS;

EID: 84888336121     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12485     Document Type: Editorial

References (5)

1. Süsal C, Opelz G., Current role of human leukocyte antigen matching in kidney transplantation. Curr Opin Organ Transplant 2013; 18: 438-444.
2. Dankers MK, Witvliet MD, Roelen DL, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004; 77: 1236-1239.
3. Weibe C, Pochinco D, Blydt-Hansen TD, et al. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant 2013; 13: 3114-3122.
4. Kosmoliaptsis V, Sharples LD, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ., Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2011; 91: 183-190.
5. Claas FHJ, Rahmel A, Doxiadis IIN., Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009; 88: 447-452.